Narrative review / 2011
A review of 62 studies proposed a carotenoid health index linking higher plasma carotenoids to lower risks of mortality, metabolic syndrome, and cancer.
Sixty-two studies of plasma carotenoids and health outcomes, primarily prospective cohort or population-based case-control designs, were analyzed to develop a carotenoid health index. Cutoff points across the 10th to 90th percentiles were established at 1.11, 1.47, 1.89, 2.52, and 3.07 µM. A low threshold effect appeared for all-cause mortality with protection above every cutoff except the lowest, whereas metabolic syndrome and cancer showed significant positive outcomes only above higher cutoffs. A proposed carotenoid health index categorized risk from very high (<1 µM) to very low (>4 µM), with over 95% of the US population falling into the moderate or high risk categories.
Shows an association, not proof of cause and effect.
- Study type
- Review of observational studies
- Who was studied
- Participants across 62 studies (mostly prospective cohort or case-control)
- What was measured
- Carotenoid health index cutoffs, all-cause mortality, metabolic syndrome, cancer
THE PAPER
A carotenoid health index based on plasma carotenoids and health outcomes.
Donaldson MS. Nutrients, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.